Search
Doc: ‘Decoy’ genome new cancer strategy
- OPACC
- Mar 28, 2016
- 1 min read
Scientists at the Dana-Farber Cancer Institute are developing tiny “decoys” to trick an aggressive childhood cancer — a tactic they say could help prevent deadly relapses and resistance to chemotherapy that remain persistent problems for young sufferers.
Recent Posts
See AllWhile the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...